STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Feb. 28, 2025	Feb. 29, 2024
Operating expenses
Research and development	$ 1,045,934	$ 864,999
General and administrative	340,273	470,432
Total operating expenses	1,386,207	1,335,431
Operating loss	(1,386,207)	(1,335,431)
Loss before provision for income tax	(1,386,207)	(1,335,431)
Net loss	$ (1,386,207)	$ (1,335,431)
Earnings per share information:
Loss per common share Basic	$ (0.01)	$ (0.01)
Loss per common share Diluted	$ (0.01)	$ (0.01)
Weighted average common shares outstanding:
Weighted average number of common shares outstanding Basic	131,448,444	131,448,444
Weighted average number of common shares outstanding Diluted	131,448,444	131,448,444